Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tatsuki Fukami

Showing results (31-40 of 177) with videos related to

Pageof 18
Sort By:
Biochemical Pharmacology|March 16, 2024
Role of carboxylesterase and arylacetamide deacetylase in drug metabolism, physiology, and pathologyMai Nagaoka, Yoshiyuki Sakai, Miki Nakajima, et al.
The Journal of Biological Chemistry|February 12, 2017
A-to-I RNA Editing Up-regulates Human Dihydrofolate Reductase in Breast CancerMasataka Nakano, Tatsuki Fukami, Saki Gotoh, et al.
Biochemical Pharmacology|March 18, 2020
SLC35B1 significantly contributes to the uptake of UDPGA into the endoplasmic reticulum for glucuronidation catalyzed by UDP-glucuronosyltransferasesKyoko Ondo, Hiroshi Arakawa, Masataka Nakano, et al.
Biochemical Pharmacology|November 11, 2019
Methylation of adenosine at the N<sup>6</sup> position post-transcriptionally regulates hepatic P450s expressionMasataka Nakano, Kyoko Ondo, Seiya Takemoto, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|July 13, 2015
Comparison of substrate specificity among human arylacetamide deacetylase and carboxylesterasesTatsuki Fukami, Motoki Kariya, Takaya Kurokawa, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 16, 2011
CYP2C9-mediated metabolic activation of losartan detected by a highly sensitive cell-based screening assayAtsushi Iwamura, Tatsuki Fukami, Hiroko Hosomi, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 27, 2012
Contributions of arylacetamide deacetylase and carboxylesterase 2 to flutamide hydrolysis in human liverYuki Kobayashi, Tatsuki Fukami, Mai Shimizu, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 21, 2006
CYP2A13 metabolizes the substrates of human CYP1A2, phenacetin, and theophyllineTatsuki Fukami, Miki Nakajima, Haruko Sakai, et al.
Chemical Research in Toxicology|February 13, 2008
Human cytochrome P450 2A13 efficiently metabolizes chemicals in air pollutants: naphthalene, styrene, and tolueneTatsuki Fukami, Miki Katoh, Hiroshi Yamazaki, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|November 15, 2021
Pirfenidone 5-hydroxylation is mainly catalysed by CYP1A2 and partly catalysed by CYP2C19 and CYP2D6 in the human liverYongjie Zhang, Rei Sato, Tatsuki Fukami, et al.
Pageof 18

Showing results (31-40 of 177) with videos related to

Sort By:
Pageof 18
Biochemical Pharmacology|March 16, 2024
Role of carboxylesterase and arylacetamide deacetylase in drug metabolism, physiology, and pathologyMai Nagaoka, Yoshiyuki Sakai, Miki Nakajima, et al.
The Journal of Biological Chemistry|February 12, 2017
A-to-I RNA Editing Up-regulates Human Dihydrofolate Reductase in Breast CancerMasataka Nakano, Tatsuki Fukami, Saki Gotoh, et al.
Biochemical Pharmacology|March 18, 2020
SLC35B1 significantly contributes to the uptake of UDPGA into the endoplasmic reticulum for glucuronidation catalyzed by UDP-glucuronosyltransferasesKyoko Ondo, Hiroshi Arakawa, Masataka Nakano, et al.
Biochemical Pharmacology|November 11, 2019
Methylation of adenosine at the N<sup>6</sup> position post-transcriptionally regulates hepatic P450s expressionMasataka Nakano, Kyoko Ondo, Seiya Takemoto, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|July 13, 2015
Comparison of substrate specificity among human arylacetamide deacetylase and carboxylesterasesTatsuki Fukami, Motoki Kariya, Takaya Kurokawa, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 16, 2011
CYP2C9-mediated metabolic activation of losartan detected by a highly sensitive cell-based screening assayAtsushi Iwamura, Tatsuki Fukami, Hiroko Hosomi, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 27, 2012
Contributions of arylacetamide deacetylase and carboxylesterase 2 to flutamide hydrolysis in human liverYuki Kobayashi, Tatsuki Fukami, Mai Shimizu, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 21, 2006
CYP2A13 metabolizes the substrates of human CYP1A2, phenacetin, and theophyllineTatsuki Fukami, Miki Nakajima, Haruko Sakai, et al.
Chemical Research in Toxicology|February 13, 2008
Human cytochrome P450 2A13 efficiently metabolizes chemicals in air pollutants: naphthalene, styrene, and tolueneTatsuki Fukami, Miki Katoh, Hiroshi Yamazaki, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|November 15, 2021
Pirfenidone 5-hydroxylation is mainly catalysed by CYP1A2 and partly catalysed by CYP2C19 and CYP2D6 in the human liverYongjie Zhang, Rei Sato, Tatsuki Fukami, et al.
Pageof 18